FibroBiologics Inc (NASDAQ:FBLG)’s traded shares stood at 1.06 million during the latest session, with the company’s beta value hitting -1.14. At the last check today, the stock’s price was $1.92, to imply an increase of 20.00% or $0.32 in intraday trading. The FBLG share’s 52-week high remains $17.75, putting it -824.48% down since that peak but still an impressive 43.75% since price per share fell to its 52-week low of $1.08. The company has a valuation of $69.90M, with an average of 0.23 million shares in intraday trading volume over the past 10 days and average of 173.34K shares over the past 3 months.

FibroBiologics Inc (NASDAQ:FBLG) trade information

After registering a 20.00% upside in the latest session, FibroBiologics Inc (FBLG) has traded red over the past five days. The 5-day price performance for the stock is 19.25%, and -15.04% over 30 days. With these gigs, the year-to-date price performance is -4.00%. Short interest in FibroBiologics Inc (NASDAQ:FBLG) saw shorts transact 2.5 million shares and set a 18.27 days time to cover.

The extremes give us $9 and $9 for target low and target high price respectively. As such, FBLG has been trading -368.75% off suggested target high and -368.75% from its likely low.

FibroBiologics Inc (FBLG) estimates and forecasts

Looking at statistics comparing FibroBiologics Inc share performance against respective industry, we note that the company has outperformed competitors. FibroBiologics Inc (FBLG) shares are -48.53% down over the last 6 months, with its year-to-date growth rate higher than industry average at 50.00% against 16.00%.

FBLG Dividends

FibroBiologics Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

We also have iShares Russell 2000 ETF and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the FibroBiologics Inc (FBLG) shares. Going by data provided on Nov 30, 2024 , iShares Russell 2000 ETF holds roughly 680.9 shares. This is just over 1.87% of the total shares, with a market valuation of $1.25 million. Data from the same date shows that the other fund manager holds a little less at 407.67, or 1.12% of the shares, all valued at about 0.75 million.